Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for INFLIXIMAB
- Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.
- Safety and Efficacy Study of hAESCs Therapy for aGVHD
- Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
- Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
- Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
- Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD
- inDuctIon tREatment With subCuTaneous Infliximab for Crohn's Disease
- TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
- Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
- Anti-Inflammatory Challenge in Schizophrenia
- HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's Disease
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis
- A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis
- Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis
- The Effect of Cilostazol on Rheumatoid Arthritis Patients
- Precise Infliximab Exposure and Pharmacodynamic Control
- Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease
- Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
- Biologic Therapy in Pediatric JIA Uveitis
- Safety of Reduced Infliximab Infusion Time
- Pentoxifylline for Treatment of Resistant Major Depression
- Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
- Infliximab and Adalimumab in Irritable Bowel Disease Patients.
- Early Proactive Therapeutic Drug Monitoring of Infliximab in Children: EPIC Study
- SOLIDARITY Finland Plus Long COVID-19
- Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis
- AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
- Topical Infliximab in Eyes With Penetrating Keratoplasty
- Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
- Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis
- Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL)
- Combined Immunosuppression for Pediatric Crohn's Disease
- Pembrolizumab + Infliximab for Metastatic Melanoma
- Top Down Versus Step up in Pediatric Ulcerative Colitis
- Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases
- Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease
- Infliximab in the Treatment of Patients With Severe COVID-19 Disease
- MIS-C Comparative Effectiveness Study
- Intravitreal Infliximab for Proliferative Vitreoretinopathy
- The OPTIMIZE Trial
- Vedolizumab for Immune Mediated Colitis
- The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety
- N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease
- Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
- Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease
- Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction Model
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19
- Immune Modulators for Treating COVID-19
- Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial
- Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis
- Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease
- Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
- A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).
- Randomised Evaluation of COVID-19 Therapy
- Exploring the Effects of Vitamin D Supplementation on the Chronic Course of Patients With Crohn's Disease With Vitamin D Deficiency
- Infliximab for Treatment of Ipilimumab Colitis
- A Clinical Trial of Infliximab for Childhood Uveitis
- Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)
- Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis
- TITRATE (inducTIon for acuTe ulceRATivE Colitis)
- Control Crohn Safe Trial
- Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
- Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia
- Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease
- Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES)
- BackToBasic: Infliximab in Chronic Low Back Pain and Modic Changes
- The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children
- Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind Multi-centre Trial (RAPID-I)
- EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis
- A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
- Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis
- Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of Arthritis
- CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis
- Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD
- Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
- Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases
- Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.
- Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease
- Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS
- Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors
- Autologous Stem Cell Transplant for Crohn's Disease
- Infliximab Accelerated Induction in Moderate to Severe Pediatric UC
- Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of Psoriasis
- Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis
- Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA
- A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
- Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation
- Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS)
- KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)
- Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers
- Dynamics of Inflammation and Its Blockade on Motivational Circuitry in Depression
- Inflammation-Induced CNS Glutamate Changes in Depression
- A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)
- Topical Infliximab for Sterile Corneal Melt
- Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC
- Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis
- Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab
- ACTHAR Therapy for Central Nervous System Sarcoidosis
- Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
- Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis
- Effectiveness of Vedolizumab in CD Patients Naïve to Anti-TNF
- Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
- Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF Therapy
- Managing Infliximab Reinduction After Temporary Discontinuation of Drug
- Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis
- Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease
- Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
- An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo
- Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
- Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
- Clinical and Molecular Phenotyping in IBD
- BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study
- Autologous Stem Cell Transplant for Refractory Crohn's Disease
- To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture
- Entyvio (Vedolizumab) Long Term Safety Study
- Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).
- Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
- Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study
- Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis
- Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade
- An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease
- Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
- TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn's Disease
- Top-down Infliximab Study in Kids With Crohn's Disease
- A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease
- Effects of Inhibiting Early Inflammation in Kidney Transplant Patients
- Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab
- The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease
- "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"
- A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis
- Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator
- Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
- A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome
- 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
- Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis
- The Efficacy of Denosumab in Active Crohn's Disease
- Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial
- An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement
- Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation
- Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial
- Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial
- Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)
- Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis
- A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy
- ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
- The NOR-SWITCH Study
- A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
- Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
- Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
- Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis
- a Single-center Registered Clinical Research of Chinese Patients With Moderate to Severe Crohn's Disease
- A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor
- Regulatory T-cells and Crohn's Disease
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Early Serum Infliximab Levels in Severe Ulcerative Colitis.
- Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease
- Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients
- Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers
- Infliximab Top-down in Pediatric Crohn
- Remicade in the Treatment of Patients With Active Ankylosing Spondylitis
- Ulcerative Colitis and Vitamin D Supplementation
- Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission
- Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis
- A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
- Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure
- Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases
- Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis
- Antibiotics and Hydroxychloroquine in Crohn's
- Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
- Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
- Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease
- Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient
- Swiss Dermatology Network of Targeted Therapies (SDNTT)
- Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α Therapy
- TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis
- A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action
- Causes of Visual Loss in Retinal Disease
- Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity
- An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy
- EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
- Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease
- Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease
- A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
- RHYTHM (Formerly Escape II Myocardium)
- Efficacy of Humira in Behcet Patients With Arthritis
- Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
- HUmira in Psoriatic Arthritis
- Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease
- Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease
- Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica
- Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis
- Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.
- A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
- Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
- A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients
- Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)
- Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)
- Switching From Adalimumab to Infliximab
- A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)
- Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA)
- Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)
- Canakinumab for Pyoderma Gangrenosum
- SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.
- Infliximab, Regulatory T Cells, IL2 and Crohn's Disease
- Drug-Disease Interaction in Crohn's Disease
- Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
- A 6-Months Infliximab Or Placebo Study In UA At High Risk Of RA:Clinical,Radiological And Synovial Benefit
- Regulatory T-cells in Psoriasis Patients as Targets for Therapy
- Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)
- Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)
- Seronegative Oligoarthritis of the Knee Study (SOKS)
- A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence
- A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis
- Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis
- Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451)
- Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab
- SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy
- An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease
- A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
- Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy
- Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
- Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)
- Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments
- A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
- Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema
- Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema
- Sleep and Immunity in Rheumatoid Arthritis : Remicade Substudy
- Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis
- TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis
- The Chinese University of Hong Kong Early Arthritis Study
- Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
- An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis
- Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
- Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)
- Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)
- The HAM Infliximab Study
- A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab
- Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)
- Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)
- Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa
- Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
- Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)
- Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis
- Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis
- An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
- Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease
- Anti-Cytokine Therapy for Vasculitis
- A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)
- Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis
- Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum
- Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis
- A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)
- Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)
- A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
- Bucillamine Study of Holding Remission After Infliximab Dose-off
- European Safety Registry in Ulcerative Colitis (P04808)
- Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)
- Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis
- A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy
- Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery
- Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)
- Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
- A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
- Effect of Anti TNFa Upon Deep Endometriosis Associated Pain
- Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies
- Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis
- Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis
- Protein and Energy Metabolism in Pediatric Crohn's Disease
- Rituximab for GVHD
- Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD
- Stop Infliximab in Patients With Crohn's Disease
- Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
- Top Down Versus Step Up Strategies in Crohn's Disease
- Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis
- Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)
- Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis
- Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)
- Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
- Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C
- Psoriasis Longitudinal Assessment and Registry (PSOLAR)
- Infliximab and Methotrexate in Ankylosing Spondylitis
- Treatment of Refractory Diabetic Macular Edema With Infliximab
- Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis
- An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)
- Adalimumab in Severe and Acute Sciatica
- A Study of Infliximab for Treatment Resistant Major Depression
- Centocor Microarray Study of Patients
- Treatment With TNF Blockade, Infliximab, in Patients With Myositis
- Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis
- Combination Methotrexate and Infliximab
- Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
- Open-Label Adalimumab for Ulcerative Colitis Patients
- A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study
- Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3)
- Lumbar Spinal Fibrosis and TNF Alpha Inhibition
- A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
- Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
- Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate
- TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )
- Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)
- Efficacy of Epidural Etanercept in the Treatment of Sciatica
- Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)
- Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)
- Etanercept in Hidradenitis Suppurativa
- Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
- Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept
- RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
- Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
- Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration
- A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
- Methotrexate in the Treatment of Axial Spondyloarthritis
- Use of Infliximab for the Treatment of Pemphigus Vulgaris
- TNF-alpha Directed Therapy in Asthma
- A Clinical Trial of Infliximab for Uveitis
- Infliximab (Remicade) for Patients With Acute Kawasaki Disease
- Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis
- A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
- A Long-term Safety Study of Infliximab (Remicade)
- Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment.
- The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)
- The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol
- Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia
- New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis
- Prednisolone in Active Ankylosing Spondylitis (AS)
- Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)
- Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
- A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis
- A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis
- GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease
- The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists
- Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis
- Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis
- A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease
- An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis
- A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.
- A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
- A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease
- A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease
- A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)
- Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation
- Islet Transplantation Using Campath-1H and Infliximab Induction
- TNFalfa Blocking Treatment of Spondylarthropathies
- COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)
- Multicenter Uveitis Steroid Treatment (MUST) Trial
- A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
- Beryllium Infliximab Study: Clinical Interventional Trial
- Etanercept for Treatment of Hidradenitis
- A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis
- A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis
- Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
- Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)
- Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease
- A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis
- Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
- Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC
- A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis
- Infliximab to Treat Non-Infectious Scleritis
- A Study of Infliximab in Patients With Sarcoidosis
- A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
- A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD
- Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease
- A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis
- Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
- CNI-1493 for Treatment of Moderate to Severe Crohn's Disease
- A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis
- A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.
- A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
- Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis
- Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
- Infliximab for the Treatment of Early Rheumatoid Arthritis
- Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys
Clinical trials list
click for details